AstraZeneca - BCG Matrix Analysis | Updated 2024

BCG Matrix for AstraZeneca

AstraZeneca Business Model and Product Analysis

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's primary areas of focus include Oncology, Cardiovascular, Renal & Metabolism (CVRM), and Respiratory & Immunology. AstraZeneca leverages its strong research and development capabilities to bring innovative treatments to market, aiming to address unmet medical needs and improve patient outcomes.

Key Products Overview

  1. Tagrisso: A leading treatment in the oncology s...
BOSTON CONSULTING GROUP (BCG) MATRIX
Question Mark
Star
Dog
Cash Cow
T
Tagrisso
S
Symbicort
F
Farxiga
C
Crestor
L
Lynparza
MARKET GROWTH
RELATIVE MARKET SHARE (low to high)

Analysis

Product Classification and Justification

  1. Tagrisso: Star Tagrisso is a leading treatment for NSCLC and has shown strong market performance, backed by solid clinical data and expanding indications. The product enjoys a dominant market share and is experiencing high growth due to its effectiveness and ongoing research.

  2. Symbicort: Cash Cow Symbicort is a well-established product in the respiratory segment with a strong market presence. Although it faces competition from other inhalers and generics, its market share remains significant. However, the growth rate is ...

Create Custom BCG Matrix

Our BCG tool allows you to fill out the matrix with your own products.

Explore BCG Matrices

AI Assistants for Your University Courses

It's like ChatGPT but for your university course. Ask questions about your course material and get instant answers with citations.